Infection Control Market
PUBLISHED: 2023 ID: SMRC24008
SHARE
SHARE

Infection Control Market

Infection Control Market Forecasts to 2030 - Global Analysis By Product & Service (Sterilization Products and Services, Cleaning and Disinfection Products, Protective Barriers and Other Infection Control Products), By End User (Hospitals, Clinics, Food Industry and Other End Users) and By Geography

4.6 (100 reviews)
4.6 (100 reviews)
Published: 2023 ID: SMRC24008

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2021-2030

Estimated Year Value (2023)

US $237.96 BN

Projected Year Value (2030)

US $426.70 BN

CAGR (2023-2030)

8.7%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

North America

Highest Growing Market

Asia Pacific


According to Stratistics MRC, the Global Infection Control Market is accounted for $237.96 billion in 2023 and is expected to reach $426.70 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Infection control refers to a set of practices and measures aimed at preventing the spread of infectious agents, such as bacteria, viruses, fungi, and parasites, within healthcare settings, community environments, or other contexts where the transmission of infections can occur. The primary goals of infection control are to protect individuals from acquiring infections and to prevent the spread of infections from one person to another.

According to the statistics published by WHO, Acute Respiratory Diseases (ARDs) is one of the major causes of high mortality rates globally. Approximately 4.0 million deaths occur every year due to ARDs.



Market Dynamics:

Driver:

Rising prevalence of hospital-acquired infections (HAIs)

Every year, unsafe and inadequate medical care results in the injuries or deaths of millions of patients. Numerous medical procedures and risks associated with healthcare significantly increase the burden of harm from inadequate care. According to the World Health Organization, complications from unsafe surgical procedures can affect up to 25% of patients. 7 to 10 out of every 100 patients in hospitals in high-income and low- and middle-income countries suffer from healthcare-associated infections. The Centers for Disease Control (CDC) also note that HAIs are thought to be responsible for 99,000 fatalities annually in addition to 1.7 million infections. Hospital infections are increasing, which has fueled demand for infection control products and accelerated market expansion.

Restraint:

Negatively effects of chemical disinfectants

The majority of chemical disinfectants currently available on the market have toxic properties. Misuse of disinfectants can put patients exposed to them and the environment in danger. The Environmental Protection Agency (EPA), which classifies these disinfection products as pesticides, requires registration for all disinfectants sold in the US. Moreover, manufacturers are currently under pressure to develop cleaner, more environmentally friendly disinfectants that are less damaging to people's eyes, like pH-neutral quaternary, butyl-free, and disinfectants based on hydrogen peroxide. Such factors impede market expansion.

Opportunity:

Growing expansion in emerging markets

The market for infection control is predicted to grow as a result of untapped opportunities, improved infrastructure for the healthcare sector, an increase in the number of pharmaceutical and medical device companies, and rising consumer demand for infection control products. The healthcare sector is expanding in emerging economies as a result of the rise in demand for more sophisticated manufacturing systems and significant government investments to upgrade healthcare infrastructure. Asian countries have experienced growth in the pharmaceutical research and medical device industries as a result of the abundance of resources available. Combining all these elements is anticipated to present a variety of opportunities for market expansion during the forecast period.

Threat:

Healthcare budget constraints and compliance challenges

Healthcare budget constraints and cost-conscious practices may limit investments in advanced infection control technologies. Market saturation and intense competition among suppliers could exert downward pressure on prices, potentially impacting profitability. Additionally, regulatory changes and compliance challenges in different regions also pose a threat, requiring companies to navigate complex standards, which further restrains market growth.

Covid-19 Impact:

The COVID-19 pandemic has profoundly impacted infection control practices worldwide. It has heightened awareness about the importance of stringent infection control measures, leading to increased demand for personal protective equipment (PPE), sanitation products, and healthcare disinfectants. Hospitals and healthcare facilities have implemented more rigorous protocols to prevent disease transmission. Additionally, the pandemic has accelerated the development and adoption of novel infection control technologies and strategies. It serves as a stark reminder of the need for robust preparedness and investment in infection control in healthcare and public spaces, further reshaping the industry to meet evolving challenges during this period.

The hospitals segment is expected to be the largest during the forecast period

The hospitals segment contributes the most to the market and is anticipated to have the largest market share during the forecast period. Hospitals contain healthcare facilities with trained medical personnel, nursing personnel, and specialized equipment. Increased government initiatives to ensure high levels of infection prevention, an increase in hospitals with cutting-edge infection control techniques, an increase in the number of surgical procedures carried out in hospitals, and an increase in the number of elderly people living alone are all factors contributing to the segment's expansion.

The sterilization products and services segment is expected to have the highest CAGR during the forecast period

During the anticipated timeframe, the segment for sterilization products and services is predicted to have the highest CAGR. Antibiotics might not be able to stop such a widespread attack, so sterilization is crucial to preventing infectious diseases from spreading throughout hospitals or other healthcare facilities. Infectious diseases claim the lives of 17 million people each year, according to the World Health Organization (WHO), which estimates that at least 30 new diseases have emerged in the last 20 years. Over the course of the forecast period, it is also anticipated that rising surgical rates, an increase in the prevalence of infectious diseases, and expansion in the healthcare sector will spur market expansion.

Region with largest share:

During the forecast period, North America is anticipated to maintain its leadership in the infection control market. Some important factors influencing market growth include the presence of major market players in the region, a well-developed healthcare infrastructure, and the widespread use of infection control technologies. The larger share seized by this region is thought to be due to a consistent number of strategic collaborations adopted by key market players to expand their product portfolio and infection control capabilities. Additionally, the established businesses' increased efforts to expand their presence throughout this region are to blame for North America's dominant market share.

Region with highest CAGR:

Asia Pacific region is expected to exhibit the highest CAGR throughout the forecast period owing to the growing presence of outsourcing organizations, growing healthcare expenditure, and the unprecedented evolution of healthcare standards and infrastructure across this region. The presence of various voluntary and government organizations focused on improving infection control standards is also one of the significant factors contributing to the growth of the Asia-Pacific region. Additionally, the increasing trend of outsourcing by established market players in developed economies to companies in the Asia-Pacific region also serves as a key growth-impelling factor for the market.



Key players in the market

Some of the key players in Infection Control Market include Ecolab Inc., Fortive Corporation (Advanced Sterilization Products), Genitge Ab, Matachana Group, Miele Group. (Steelco), MMM Group, Sotera Health Inc and Steris PLC.

Key Developments:

In September 2023, 3M reported that both the split-off exchange offer for 3M common stock and the closure of the merger of Garden SpinCo Corporation ("SpinCo"), the 3M subsidiary owning the food safety business, with a subsidiary of Neogen Corporation had been completed ("Neogen").

In June 2023, Social care nurses in Scotland can now access the latest infection prevention and control (IPC) guidance in their pocket thanks to a new app launched this week. It was developed in partnership between the Scottish Social Services Council (SSSC), NHS Education for Scotland (NES) and the Digital Health & Care Innovation Centre (DHI).

In May 2023, Getinge announced an agreement to acquire High Purity New England, Inc., a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. Getinge has paid approximately SEK 1,330 M (USD 120 M) in cash on closing, on a cash and debt free basis for 100 % of the shares. In addition, a maximum earn out of approximately SEK 1,880 M (USD 170 M) can be paid out during 2024 - 2026 if agreed net revenue performance milestones are achieved in 2023 – 2025.

Product & Services Covered:
• Sterilization Products and Services
• Cleaning and Disinfection Products
• Protective Barriers
• Endoscope Reprocessing Products
• Other Infection Control Products

End Users Covered:
• Hospitals
• Clinics
• Food Industry
• Laboratories
• Medical Device Companies
• Pharmaceutical Companies
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Infection Control Market, By Product & Service
5.1 Introduction
5.2 Sterilization Products and Services
5.2.1 Sterilization Equipment
5.2.1.1 Heat Sterilization Equipment
5.2.1.1.1 Dry Heat Sterilizers
5.2.1.1.2 Moist Heat Sterilizers
5.2.1.2 Low-Temperature Sterilization
5.2.1.2.1 Ethylene Oxide Sterilization (ETO)
5.2.1.2.2 Formaldehyde Sterilization
5.2.1.2.3 Hydrogen Peroxide Sterilization
5.2.1.2.4 Other Low-Temperature Sterilization
5.2.1.3 Filtration Sterilization
5.2.1.4 Radiation Sterilization
5.2.1.5 Other Equipments
5.2.2 Contract Sterilization Services
5.2.2.1 E-Beam Sterilization Services
5.2.2.2 ETO Sterilization Services
5.2.2.3 Gamma Sterilization Services
5.2.2.4 Steam Sterilization Services
5.2.2.5 Other Sterilization Services
5.2.3 Consumables and Accessories
5.2.3.1 Sterilization Indicators
5.2.3.1.1 Biological Indicators
5.2.3.1.2 Chemical Indicators
5.2.3.2 Packaging Accessories
5.3 Cleaning and Disinfection Products
5.3.1 Disinfectants
5.3.1.1 Product Type
5.3.1.1.1 Hand Disinfectants
5.3.1.1.2 Instrument Disinfectants
5.3.1.1.3 Skin Disinfectants
5.3.1.1.4 Surface Disinfectants
5.3.1.2 Formulation
5.3.1.1 Disinfectant Sprays
5.3.1.2 Disinfectant Wipes
5.3.1.3 Liquid Disinfectants
5.3.1.3 Environmental Protection Agency (EPA) Classification
5.3.1.3.1 High-Level Disinfectants
5.3.1.3.2 Intermediate-Level Disinfectants
5.3.1.3.3 Low-Level Disinfectants
5.3.2 Cleaning and Disinfection Equipment
5.3.2.1 Flusher Disinfectors
5.3.2.2 Ultrasonic Cleaners
5.3.2.3 UV-Ray Disinfectors
5.3.2.4 Washer Disinfectors
5.3.2.5 Other Cleaning and Disinfection Equipments
5.3.3 Disinfection and Cleaning Accessories
5.3.4 Lubricants and Cleaning Solutions
5.4 Protective Barriers
5.4.1 Medical Nonwovens
5.4.1.1 Face Masks
5.4.1.2 Surgical Drapes
5.4.1.3 Surgical Gowns
5.4.2 Covers and Closures
5.4.3 Gloves
5.4.4 Goggles
5.5 Endoscope Reprocessing Products
5.5.1 Endoscope Reprocessing Consumables
5.5.2 Endoscope Reprocessing Equipment
5.5.2.1 Automated Endoscope Reprocessors
5.5.2.2 Endoscope Tracking Systems
5.5.3 Other Endoscope Reprocessing Products
5.6 Other Infection Control Products

6 Global Infection Control Market, By End User
6.1 Introduction
6.2 Hospitals
6.3 Clinics
6.4 Food Industry
6.5 Laboratories
6.6 Medical Device Companies
6.7 Pharmaceutical Companies
6.8 Other End Users

7 Global Infection Control Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 3M Company
9.2 Advanced Sterilization Products
9.3 Belimed Ag.
9.4 Cantel Medical Corporation
9.5 Ecolab Inc.
9.6 Fortive Corporation (Advanced Sterilization Products).
9.7 Genitge Ab.
9.8 Matachana Group.
9.9 Miele Group. (Steelco)
9.10 MMM Group
9.11 Sotera Health Inc.
9.12 Steris PLC

List of Tables
1 Global Infection Control Market Outlook, By Region (2021-2030) ($MN)
2 Global Infection Control Market Outlook, By Product & Service (2021-2030) ($MN)
3 Global Infection Control Market Outlook, By Sterilization Products and Services (2021-2030) ($MN)
4 Global Infection Control Market Outlook, By Sterilization Equipment (2021-2030) ($MN)
5 Global Infection Control Market Outlook, By Heat Sterilization Equipment (2021-2030) ($MN)
6 Global Infection Control Market Outlook, By Low-Temperature Sterilization (2021-2030) ($MN)
7 Global Infection Control Market Outlook, By Filtration Sterilization (2021-2030) ($MN)
8 Global Infection Control Market Outlook, By Radiation Sterilization (2021-2030) ($MN)
9 Global Infection Control Market Outlook, By Other Equipments (2021-2030) ($MN)
10 Global Infection Control Market Outlook, By Contract Sterilization Services (2021-2030) ($MN)
11 Global Infection Control Market Outlook, By E-Beam Sterilization Services (2021-2030) ($MN)
12 Global Infection Control Market Outlook, By ETO Sterilization Services (2021-2030) ($MN)
13 Global Infection Control Market Outlook, By Gamma Sterilization Services (2021-2030) ($MN)
14 Global Infection Control Market Outlook, By Steam Sterilization Services (2021-2030) ($MN)
15 Global Infection Control Market Outlook, By Other Sterilization Services (2021-2030) ($MN)
16 Global Infection Control Market Outlook, By Consumables and Accessories (2021-2030) ($MN)
17 Global Infection Control Market Outlook, By Sterilization Indicators (2021-2030) ($MN)
18 Global Infection Control Market Outlook, By Packaging Accessories (2021-2030) ($MN)
19 Global Infection Control Market Outlook, By Cleaning and Disinfection Products (2021-2030) ($MN)
20 Global Infection Control Market Outlook, By Disinfectants (2021-2030) ($MN)
21 Global Infection Control Market Outlook, By Product Type (2021-2030) ($MN)
22 Global Infection Control Market Outlook, By Formulation (2021-2030) ($MN)
23 Global Infection Control Market Outlook, By Environmental Protection Agency (EPA) Classification (2021-2030) ($MN)
24 Global Infection Control Market Outlook, By Cleaning and Disinfection Equipment (2021-2030) ($MN)
25 Global Infection Control Market Outlook, By Flusher Disinfectors (2021-2030) ($MN)
26 Global Infection Control Market Outlook, By Ultrasonic Cleaners (2021-2030) ($MN)
27 Global Infection Control Market Outlook, By UV-Ray Disinfectors (2021-2030) ($MN)
28 Global Infection Control Market Outlook, By Washer Disinfectors (2021-2030) ($MN)
29 Global Infection Control Market Outlook, By Other Cleaning and Disinfection Equipments (2021-2030) ($MN)
30 Global Infection Control Market Outlook, By Disinfection and Cleaning Accessories (2021-2030) ($MN)
31 Global Infection Control Market Outlook, By Lubricants and Cleaning Solutions (2021-2030) ($MN)
32 Global Infection Control Market Outlook, By Protective Barriers (2021-2030) ($MN)
33 Global Infection Control Market Outlook, By Medical Nonwovens (2021-2030) ($MN)
34 Global Infection Control Market Outlook, By Face Masks (2021-2030) ($MN)
35 Global Infection Control Market Outlook, By Surgical Drapes (2021-2030) ($MN)
36 Global Infection Control Market Outlook, By Surgical Gowns (2021-2030) ($MN)
37 Global Infection Control Market Outlook, By Covers and Closures (2021-2030) ($MN)
38 Global Infection Control Market Outlook, By Gloves (2021-2030) ($MN)
39 Global Infection Control Market Outlook, By Goggles (2021-2030) ($MN)
40 Global Infection Control Market Outlook, By Endoscope Reprocessing Products (2021-2030) ($MN)
41 Global Infection Control Market Outlook, By Endoscope Reprocessing Consumables (2021-2030) ($MN)
42 Global Infection Control Market Outlook, By Endoscope Reprocessing Equipment (2021-2030) ($MN)
43 Global Infection Control Market Outlook, By Automated Endoscope Reprocessors (2021-2030) ($MN)
44 Global Infection Control Market Outlook, By Endoscope Tracking Systems (2021-2030) ($MN)
45 Global Infection Control Market Outlook, By Other Endoscope Reprocessing Products (2021-2030) ($MN)
46 Global Infection Control Market Outlook, By Other Infection Control Products (2021-2030) ($MN)
47 Global Infection Control Market Outlook, By End User (2021-2030) ($MN)
48 Global Infection Control Market Outlook, By Hospitals (2021-2030) ($MN)
49 Global Infection Control Market Outlook, By Clinics (2021-2030) ($MN)
50 Global Infection Control Market Outlook, By Food Industry (2021-2030) ($MN)
51 Global Infection Control Market Outlook, By Laboratories (2021-2030) ($MN)
52 Global Infection Control Market Outlook, By Medical Device Companies (2021-2030) ($MN)
53 Global Infection Control Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
54 Global Infection Control Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

List of Figures
Figure 1 Global Infection Control Market Outlook (2021-2030) ($MN)
Figure 2 North America Infection Control Market Outlook (2021-2030) ($MN)
Figure 3 US Infection Control Market Outlook (2021-2030) ($MN)
Figure 4 Canada Infection Control Market Outlook (2021-2030) ($MN)
Figure 5 Mexico Infection Control Market Outlook (2021-2030) ($MN)
Figure 6 Europe Infection Control Market Outlook (2021-2030) ($MN)
Figure 7 Germany Infection Control Market Outlook (2021-2030) ($MN)
Figure 8 UK Infection Control Market Outlook (2021-2030) ($MN)
Figure 9 Italy Infection Control Market Outlook (2021-2030) ($MN)
Figure 10 France Infection Control Market Outlook (2021-2030) ($MN)
Figure 11 Spain Infection Control Market Outlook (2021-2030) ($MN)
Figure 12 Rest of Europe Infection Control Market Outlook (2021-2030) ($MN)
Figure 13 Asia Pacific Infection Control Market Outlook (2021-2030) ($MN)
Figure 14 Japan Infection Control Market Outlook (2021-2030) ($MN)
Figure 15 China Infection Control Market Outlook (2021-2030) ($MN)
Figure 16 India Infection Control Market Outlook (2021-2030) ($MN)
Figure 17 Australia Infection Control Market Outlook (2021-2030) ($MN)
Figure 18 New Zealand Infection Control Market Outlook (2021-2030) ($MN)
Figure 19 South Korea Infection Control Market Outlook (2021-2030) ($MN)
Figure 20 Rest of Asia Pacific Infection Control Market Outlook (2021-2030) ($MN)
Figure 21 South America Infection Control Market Outlook (2021-2030) ($MN)
Figure 22 Argentina Infection Control Market Outlook (2021-2030) ($MN)
Figure 23 Brazil Infection Control Market Outlook (2021-2030) ($MN)
Figure 24 Chile Infection Control Market Outlook (2021-2030) ($MN)
Figure 25 Rest of South America Infection Control Market Outlook (2021-2030) ($MN)
Figure 26 Middle East & Africa Infection Control Market Outlook (2021-2030) ($MN)
Figure 27 Saudi Arabia Infection Control Market Outlook (2021-2030) ($MN)
Figure 28 UAE Infection Control Market Outlook (2021-2030) ($MN)
Figure 29 Qatar Infection Control Market Outlook (2021-2030) ($MN)
Figure 30 South Africa Infection Control Market Outlook (2021-2030) ($MN)
Figure 31 Rest of Middle East & Africa Infection Control Market Outlook (2021-2030) ($MN)

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials